05-Oct-17 Chinese drug firm Fosun Pharma has acquired a 74% controlling interest of Hyderabad based Gland Pharma at a valuation of USD1.1 bn. The new owners intend to keep present management in charge of the day-to-day running of the company. [image: Gland Pharma Limited]

03-Oct-17 Beijing Hospital, one of China's leading public hospitals, is to implement OmniComm's phase I clinic trial automation solution, bringing the number of China clients for its TrialOne medical trial data management solution to seven. [image: OmniComm Systems Inc]

28-Sep-17 In Jun-17 Myanmar relaxed prohibitions on foreign trading, allowing 100% foreign-owned companies to sell certain hospital equipment. Myanmar needs to be less reliant on offshore manufacturing. With the increase in private medical insurance, opportunities abound for investors. [image: The Myanmar Times]

28-Sep-17 According to the Korean government's biotechnology development plan, the government will increase the number of new drug candidates by 100 to 185 in 2026 and help companies come up with at least five new blockbuster drugs. [image: Business Korea]

13-Sep-17 Golden Equator business group signed a MoU with a Korean contract research organization, C&R Healthcare Global, to launch the Korea-Singapore Healthcare Incubator. The Incubator will help 10-15 Korean health companies expand into Singapore and Southeast Asia. [image: image@Buro Ole Schreeren]